| 摘要 |
COMPOUNDS OF THE FORMULA AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF. AS USED IN FORMULA I, AND THROUGHOUT THE SPECIFICATION, THE SYMBOLS HAVE THE FOLLOWING MEANINGS: R1 AND R2 ARE INDEPENDENTLY HYDROGEN, FLUORINE OR ALKYL; R3 IS ARYL OR HETEROARYL R4 IS HYDROGEN, ALKYL, CYCLOALKYL, ARYL, CYCLOALKYLALKYL, ARYLALKYL, HETEROARYL, HETEROARYLALKYL, HETEROCYCLOALKYL, HETEROCYCLOALKYLALKYL; OR CO-ALKYL, CONH-ALKYL, COO-ALKYL, SO2-ALKYL, C(NCN)NH-ALKYL, C(NNO2)NH-ALKYL, C(NH)NH-ALKYL , C(NH)NHCO-ALKYL , C(NOR6)NH-ALKYL , R5 IS HYDROGEN OR ALKYL; R6 IS HYDROGEN, ALKYL, CYCLOALKYL, ARYL, CYCLOALKYLAKYL, ARYLALKYL, HETEROARYL, HETEROARYLALKYL, HETEROCYCLOALKYL OR HETEROCYCLOALKYLALKYL; M IS AN INTEGER OF 0 TO 2; AND N IS AN INTEGER OF 1 TO 3. THE COMPOUNDS OF FORMULA I ARE PROTEIN KINASE INHIBITORS AND ARE USEFUL IN THE TREATMENT AND PREVENTION OF PROLIFERATIVE DISEASES, FOR EXAMPLE, CANCER, INFLAMMATION AND ARTHRITIS. THEY MAY ALSO BE USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS ALZHEIMER'S DISEASE, CARDIOVASCULAR DISEASES, VIRAL DISEASES AND FUNGAL DISEASES.
|
